Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Trastuzumab deruxtecan yields promising results in HER2-positive breast cancer patients pretreated with TDM-1

Dr Ian Krop - Dana Farber Cancer Institute, Boston, USA
Trastuzumab deruxtecan yields promising results in HER2-positive breast cancer patients pretreated with TDM-1 ( Dr Ian Krop - Dana Farber Cancer Institute, Boston, USA )
18 Dec 2019

KEYNOTE-522 updates: Pembrolizumab plus neoadjuvant chemotherapy in early triple-negative breast cancer

Prof Peter Schmid - St Bartholomew's Hospital London, London, UK
KEYNOTE-522 updates: Pembrolizumab plus neoadjuvant chemotherapy in early triple-negative breast cancer ( Prof Peter Schmid - St Bartholomew's Hospital London, London, UK )
18 Dec 2019

Challenges of treating elderly breast cancer patients

Dr Richard Simcock - Sussex Cancer Centre, Brighton, UK
Challenges of treating elderly breast cancer patients ( Dr Richard Simcock - Sussex Cancer Centre, Brighton, UK )
29 Nov 2019

Breast cancer in older adults: A multidisciplinary view

Dr Enrique Soto - National Institute of Medical Sciences, Mexico City, Mexico
Breast cancer in older adults: A multidisciplinary view ( Dr Enrique Soto - National Institute of Medical Sciences, Mexico City, Mexico )
29 Nov 2019

Treating breast cancer in the elderly

Prof Kwok-Leung Cheung - University of Nottingham, Nottingham, UK
Treating breast cancer in the elderly ( Prof Kwok-Leung Cheung - University of Nottingham, Nottingham, UK )
29 Nov 2019

Should breast and colorectal cancer screening be carried out in older adults?

Dr Shabbir Alibhai - Princess Margaret Cancer, Toronto, Canada
Should breast and colorectal cancer screening be carried out in older adults? ( Dr Shabbir Alibhai - Princess Margaret Cancer, Toronto, Canada )
29 Nov 2019

Cancer early detection: Strategies, barriers and solutions

Dr Ophira Ginsburg - NYU Langone Health, New York City, USA
Cancer early detection: Strategies, barriers and solutions ( Dr Ophira Ginsburg - NYU Langone Health, New York City, USA )
6 Nov 2019

Analysis of assay used in IMpassion130 to guide treatment of metastatic and advanced breast cancers

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
Analysis of assay used in IMpassion130 to guide treatment of metastatic and advanced breast cancers ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
31 Oct 2019

Treatment pathways for patients with triple-negative breast cancer

Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA
Treatment pathways for patients with triple-negative breast cancer ( Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA )
23 Oct 2019

PARP inhibitors in metastatic breast cancer: The present and the future

Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA
PARP inhibitors in metastatic breast cancer: The present and the future ( Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA )
23 Oct 2019

Shaping the future of metastasis - ecancer investigates

Monique Biryiana - ecancer Medical Reporter, Dr Chris Bakal - Dynamical Cell Systems Team Leader, Patricia Pascual Vargas - PhD Student
Shaping the future of metastasis - ecancer investigates ( Monique Biryiana - ecancer Medical Reporter, Dr Chris Bakal - Dynamical Cell Systems Team Leader, Patricia Pascual Vargas - PhD Student )
14 Oct 2019

PARP inhibitors for metastatic breast cancer

Prof Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany
PARP inhibitors for metastatic breast cancer ( Prof Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany )
7 Oct 2019